Lina Gunnarsson1, Jason R Snape2, Bas Verbruggen1, Stewart F Owen3, Erik Kristiansson4, Luigi Margiotta-Casaluci5, Tobias Österlund4, Kathryn Hutchinson3, Dean Leverett6, Becky Marks6, Charles R Tyler7. 1. Biosciences, College of Life & Environmental Sciences, University of Exeter, Exeter, Devon EX4 4QD, UK. 2. AstraZeneca, Global Environment, Alderley Park, Macclesfield, Cheshire SK10 4TF, UK; School of Life Sciences, Gibbet Hill Campus, the University of Warwick, Coventry CV4 7AL, UK. 3. AstraZeneca, Global Environment, Alderley Park, Macclesfield, Cheshire SK10 4TF, UK. 4. Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, SE-412 96 Gothenburg, Sweden. 5. Brunel University London, Institute of Environment, Health and Societies, London UB8 3PH, UK. 6. WCA, Brunel House, Volunteer Way, Faringdon, Oxfordshire SN7 7YR, UK. 7. Biosciences, College of Life & Environmental Sciences, University of Exeter, Exeter, Devon EX4 4QD, UK. Electronic address: C.R.Tyler@exeter.ac.uk.
Abstract
BACKGROUND: The presence of pharmaceuticals in the environment is a growing global concern and although environmental risk assessment is required for approval of new drugs in Europe and the USA, the adequacy of the current triggers and the effects-based assessments has been questioned. OBJECTIVE: To provide a comprehensive analysis of all regulatory compliant aquatic ecotoxicity data and evaluate the current triggers and effects-based environmental assessments to facilitate the development of more efficient approaches for pharmaceuticals toxicity testing. METHODS: Publicly-available regulatory compliant ecotoxicity data for drugs targeting human proteins was compiled together with pharmacological information including drug targets, Cmax and lipophilicity. Possible links between these factors and the ecotoxicity data for effects on, growth, mortality and/or reproduction, were evaluated. The environmental risks were then assessed based on a combined analysis of drug toxicity and predicted environmental concentrations based on European patient consumption data. RESULTS: For most (88%) of the of 975 approved small molecule drugs targeting human proteins a complete set of regulatory compliant ecotoxicity data in the public domain was lacking, highlighting the need for both intelligent approaches to prioritize legacy human drugs for a tailored environmental risk assessment and a transparent database that captures environmental data. We show that presence/absence of drug-target orthologues are predictive of susceptible species for the more potent drugs. Drugs that target the endocrine system represent the highest potency and greatest risk. However, for most drugs (>80%) with a full set of ecotoxicity data, risk quotients assuming worst-case exposure assessments were below one in all European countries indicating low environmental risks for the endpoints assessed. CONCLUSION: We believe that the presented analysis can guide improvements to current testing procedures, and provide valuable approaches for prioritising legacy drugs (i.e. those registered before 2006) for further ecotoxicity testing. For drugs where effects of possible concern (e.g. behaviour) are not captured in regulatory tests, additional mechanistic testing may be required to provide the highest confidence for avoiding environmental impacts.
BACKGROUND: The presence of pharmaceuticals in the environment is a growing global concern and although environmental risk assessment is required for approval of new drugs in Europe and the USA, the adequacy of the current triggers and the effects-based assessments has been questioned. OBJECTIVE: To provide a comprehensive analysis of all regulatory compliant aquatic ecotoxicity data and evaluate the current triggers and effects-based environmental assessments to facilitate the development of more efficient approaches for pharmaceuticals toxicity testing. METHODS: Publicly-available regulatory compliant ecotoxicity data for drugs targeting human proteins was compiled together with pharmacological information including drug targets, Cmax and lipophilicity. Possible links between these factors and the ecotoxicity data for effects on, growth, mortality and/or reproduction, were evaluated. The environmental risks were then assessed based on a combined analysis of drug toxicity and predicted environmental concentrations based on European patient consumption data. RESULTS: For most (88%) of the of 975 approved small molecule drugs targeting human proteins a complete set of regulatory compliant ecotoxicity data in the public domain was lacking, highlighting the need for both intelligent approaches to prioritize legacy human drugs for a tailored environmental risk assessment and a transparent database that captures environmental data. We show that presence/absence of drug-target orthologues are predictive of susceptible species for the more potent drugs. Drugs that target the endocrine system represent the highest potency and greatest risk. However, for most drugs (>80%) with a full set of ecotoxicity data, risk quotients assuming worst-case exposure assessments were below one in all European countries indicating low environmental risks for the endpoints assessed. CONCLUSION: We believe that the presented analysis can guide improvements to current testing procedures, and provide valuable approaches for prioritising legacy drugs (i.e. those registered before 2006) for further ecotoxicity testing. For drugs where effects of possible concern (e.g. behaviour) are not captured in regulatory tests, additional mechanistic testing may be required to provide the highest confidence for avoiding environmental impacts.
Authors: Laura Lomba; David Lapeña; Natalia Ros; Elena Aso; Mariachiara Cannavò; Diego Errazquin; Beatriz Giner Journal: Environ Sci Pollut Res Int Date: 2020-01-11 Impact factor: 4.223
Authors: Natalie Burden; Rachel Benstead; Kate Benyon; Mark Clook; Christopher Green; John Handley; Neil Harper; Samuel K Maynard; Chris Mead; Audrey Pearson; Kathryn Ryder; Dave Sheahan; Roger van Egmond; James R Wheeler; Thomas H Hutchinson Journal: Environ Toxicol Chem Date: 2020-08-24 Impact factor: 3.742
Authors: John L Wilkinson; Alistair B A Boxall; Dana W Kolpin; Kenneth M Y Leung; Racliffe W S Lai; Cristóbal Galbán-Malagón; Aiko D Adell; Julie Mondon; Marc Metian; Robert A Marchant; Alejandra Bouzas-Monroy; Aida Cuni-Sanchez; Anja Coors; Pedro Carriquiriborde; Macarena Rojo; Chris Gordon; Magdalena Cara; Monique Moermond; Thais Luarte; Vahagn Petrosyan; Yekaterina Perikhanyan; Clare S Mahon; Christopher J McGurk; Thilo Hofmann; Tapos Kormoker; Volga Iniguez; Jessica Guzman-Otazo; Jean L Tavares; Francisco Gildasio De Figueiredo; Maria T P Razzolini; Victorien Dougnon; Gildas Gbaguidi; Oumar Traoré; Jules M Blais; Linda E Kimpe; Michelle Wong; Donald Wong; Romaric Ntchantcho; Jaime Pizarro; Guang-Guo Ying; Chang-Er Chen; Martha Páez; Jina Martínez-Lara; Jean-Paul Otamonga; John Poté; Suspense A Ifo; Penelope Wilson; Silvia Echeverría-Sáenz; Nikolina Udikovic-Kolic; Milena Milakovic; Despo Fatta-Kassinos; Lida Ioannou-Ttofa; Vladimíra Belušová; Jan Vymazal; María Cárdenas-Bustamante; Bayable A Kassa; Jeanne Garric; Arnaud Chaumot; Peter Gibba; Ilia Kunchulia; Sven Seidensticker; Gerasimos Lyberatos; Halldór P Halldórsson; Molly Melling; Thatikonda Shashidhar; Manisha Lamba; Anindrya Nastiti; Adee Supriatin; Nima Pourang; Ali Abedini; Omar Abdullah; Salem S Gharbia; Francesco Pilla; Benny Chefetz; Tom Topaz; Koffi Marcellin Yao; Bakhyt Aubakirova; Raikhan Beisenova; Lydia Olaka; Jemimah K Mulu; Peter Chatanga; Victor Ntuli; Nathaniel T Blama; Sheck Sherif; Ahmad Zaharin Aris; Ley Juen Looi; Mahamoudane Niang; Seydou T Traore; Rik Oldenkamp; Olatayo Ogunbanwo; Muhammad Ashfaq; Muhammad Iqbal; Ziad Abdeen; Aaron O'Dea; Jorge Manuel Morales-Saldaña; María Custodio; Heidi de la Cruz; Ian Navarrete; Fabio Carvalho; Alhaji Brima Gogra; Bashiru M Koroma; Vesna Cerkvenik-Flajs; Mitja Gombač; Melusi Thwala; Kyungho Choi; Habyeong Kang; John L Celestino Ladu; Andreu Rico; Priyanie Amerasinghe; Anna Sobek; Gisela Horlitz; Armin K Zenker; Alex C King; Jheng-Jie Jiang; Rebecca Kariuki; Madaka Tumbo; Ulas Tezel; Turgut T Onay; Julius B Lejju; Yuliya Vystavna; Yuriy Vergeles; Horacio Heinzen; Andrés Pérez-Parada; Douglas B Sims; Maritza Figy; David Good; Charles Teta Journal: Proc Natl Acad Sci U S A Date: 2022-02-22 Impact factor: 11.205
Authors: Michael G Bertram; Jake M Martin; Erin S McCallum; Lesley A Alton; Jack A Brand; Bryan W Brooks; Daniel Cerveny; Jerker Fick; Alex T Ford; Gustav Hellström; Marcus Michelangeli; Shinichi Nakagawa; Giovanni Polverino; Minna Saaristo; Andrew Sih; Hung Tan; Charles R Tyler; Bob B M Wong; Tomas Brodin Journal: Biol Rev Camb Philos Soc Date: 2022-03-01
Authors: Alejandra Bouzas-Monroy; John L Wilkinson; Molly Melling; Alistair B A Boxall Journal: Environ Toxicol Chem Date: 2022-06-22 Impact factor: 4.218